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Norovirus (NoV) is the leading cause of gastroenteritis worldwide. A robust cell culture
system does not exist for NoV and therefore detailed characterization of outbreak
and sporadic strains relies on molecular techniques. In this study, we employed a
metagenomic approach that uses non-specific amplification followed by next-generation
sequencing to whole genome sequence NoV genomes directly from clinical samples
obtained from 8 linked patients. Enough sequencing depth was obtained for each
sample to use a de novo assembly of near-complete genome sequences. The resultant
consensus sequences were then used to identify inter-host nucleotide variations that
occur after direct transmission, analyze amino acid variations in the major capsid protein,
and provide evidence of recombination events. The analysis of intra-host quasispecies
diversity was possible due to high coverage-depth. We also observed a linear relationship
between NoV viral load in the clinical sample and the number of sequence reads that
could be attributed to NoV. The method demonstrated here has the potential for future
use in whole genome sequence analyses of other RNA viruses isolated from clinical,
environmental, and food specimens.
Keywords: norovirus, next-generation sequencing (NGS), linked patients, genetic variation, antigenic variation,
recombination
INTRODUCTION
Human norovirus (NoV) belongs to Caliciviridae family and its genome is comprised of a single
stranded, positive sense RNA that contains 3 open reading frames (ORFs) coding for 9 non-
structural and structural proteins (Green, 2013). NoV is the most frequent cause of infectious
gastroenteritis worldwide (Scallan et al., 2011; Havelaar et al., 2015). While NoV infections are
generally acute and self-limiting, persistent infections have been reported in immunocompromised
and elderly patients (Aoki et al., 2010; Belliot et al., 2014; Green, 2014).
Abbreviations: NGS, Next-generation Sequencing; NoV, Norovirus; ORF, Open reading frame; RdRp, RNA dependent RNA
polymerase; WGS, Whole genome sequencing.
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Based on genetic diversity in the capsid region NoVs are
divided into 6 genogroups (GI–GVI) which are further divided
into 36 genotypes (Kroneman et al., 2011; Vinje, 2015; Sarvestani
et al., 2016). Nine genotypes of GI NoVs, 22 genotypes of GII, and
a single genotype of GIV and GVI are known to affect humans
(Ramirez et al., 2008; Bull and White, 2011; Moore et al., 2015).
Genogroup II is the most prevalent genogroup, which accounts
for 96% of all infections, and GII.4 is the most common genotype
globally (Bull and White, 2011; Eden et al., 2013; Vega et al.,
2014). NoVs are known to undergo rapid evolution. The overall
mutation rate for the viral capsid protein, which determines the
antigenic profile, is 4.16 × 10−3 nucleotide substitutions per
site per year and this rate is consistent with other RNA viruses
(10−3–10−5 per site per year). Themutation rate is slightly higher
for GII.4 (4.3 × 10−3 per site per year), and this is believed to
provide the GII.4 strains with higher epidemiological fitness (Bull
et al., 2010; Boon et al., 2011). There is evidence that GII.17 is
replacing GII.4 as the predominant genotype in certain parts of
the world, but detailed epidemiological studies have yet to be
conducted to determine the mutation rate of GII.17 (Chan et al.,
2015; Chen et al., 2015; de Graaf et al., 2015; Parra and Green,
2015). Genetic diversity also has fitness benefits for NoV, such
as increased viral replication, antigenic variability, and enhanced
virulence. Antigenic variability is particularly important since
antigenic epitopes are under constant evolutionary pressure from
the host immune system and novel strain emergence often results
in pandemic NoV outbreaks (Karst and Baric, 2015; de Graaf
et al., 2016). Therefore, the ability to identify intra- and inter-host
NoV genetic diversity and evolutionary hotspots could lead to a
better understanding of the processes underlying viral evolution
and novel strain emergence, and this has the potential to aid in
vaccine development.
NoV can be spread through multiple routes; although,
person-to-person and foodborne transmission are the most
common (Hall et al., 2013; Barclay et al., 2014; Verhoef et al.,
2015). Due to lack of surveillance data, attribution of NoV
cases or outbreaks to specific food commodities, as well as
determining the direction of NoV transmission after person-
to-person spread is often challenging (Barclay et al., 2014;
Moore et al., 2015). An effective approach to controlling
NoV infection is to understand the mechanism and direction
of transmission and then to enact an effective intervention
strategy.
Whole genome sequencing (WGS) data can be used to
elucidate phylogenetic relationships, monitor the transmission
chains and evolution of viruses. For example, during the recent
(2014–2016) Ebola outbreak, a WGS approach was adopted
to reveal valuable information regarding the viral transmission
dynamics, genomic variations (Gire et al., 2014), and allowed
for identification of new signatures for prediction of emerging
strains (Sozhamannan et al., 2015). Post-outbreak, retrospective
WGS analysis can also be performed on NoV strains to examine
quasispecies evolution and predict the development of emerging
strains through identification of rare variants with predictable
signatures that could render predominance. Therefore, WGS
analysis of NoV has the potential to provide fast and accurate
source attribution, tracking of transmission direction, and
prediction of emerging strains (Kundu et al., 2013; Barclay et al.,
2014; Karst and Baric, 2015).
Next-generation sequencing (NGS) approaches now offer
routine WGS in research and testing laboratories; however,
NGS protocols have yet to be developed for all potential
applications (Ronholm et al., 2016). WGS of NoV, directly from
clinical samples is routinely accomplished by performing RT-
PCR to amplify viral RNA using several sequence-specific and
overlapping primer sets (Kundu et al., 2013; Cotten et al., 2014).
However, the use of sequence-specific primer sets introduces
amplification bias and the assembly of amplicons into WGS
assumes conserved viral synteny, this result in overlooking
genomic variations. Also, generating whole genome sequences
using this approach for even small number of samples is laborious
(Thomson et al., 2016). Recently a target enrichment library
preparation approach based on SureSelect sequence-specific
probes was successfully employed for WGS analysis of NoVs
from clinical samples (Brown et al., 2016). While this approach
overcomes the problem of primer design in amplicon sequencing,
it is costly, requires the prior knowledge of genotype, and is only
more effective compared to conventional RNA-Seq approach for
samples with low viral loads (Thomson et al., 2016). In this study,
we have employed a rapid and unbiased metagenomic NGS
approach for NoV from clinical samples, which also provides
enough coverage depth for identification ofminor variants within
viral quasispecies (Mancuso et al., 2011; Iles et al., 2015). Bias
was further reduced by using de novo assembly. In each case
sequencing coverage was sufficient for assembly into a single
contiguous sequence. We have also performed a comprehensive
genomic analysis during direct transmission of NoV from one
patient to another by investigating NoV infection in linked
patients. We analyzed the data to provide a detailed description
of the viral genome and the presence of inter- and intra-host
variants, as well as genome-wide recombination events.
MATERIALS AND METHODS
Sample Collection and Preparation
Fecal samples from families in Ottawa, Ontario who reported
symptoms of diarrhea and vomiting were submitted to the
National Food Virology Reference Centre at Health Canada for
verification of NoV infection. We chose 8 NoV positive samples
from 4 families submitted 2013–2015 for our study (Table 1).
In all cases the source of original transmission was most likely
person-to-person and the direction of transmission was known
through the recorded epidemiological data. In family A patient
13–38 infected 13–39, in family B 14–55 infected 14–56, in family
C14–58 infected 14–59, and in family D15–65 infected 15–66. In
each transmission event the infectious source was a toddler, and
the secondary infection was a parent for families A, B, and D, and
a sibling for family C.
Ten percent stool suspensions were clarified by centrifugation
(6000 × g for 5min) and the supernatant was filtered through
a 0.45 µM then 0.22 µM filter (Millipore, Etobicoke, Ontario,
Canada). RNA was extracted from filtrate using the Viral RNA
Mini Kit (Qiagen, Mississauga, Ontario, Canada) according to
themanufacturer’s protocol. Reverse transcription (RT)-PCRwas
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TABLE 1 | De novo assembly of NoV genomes from clinical samples obtained from linked patients.
Family group Sample ID Genotype Viral Load Total no. Reads Total Viral Reads % Viral Reads Fold Coverage
A 13–38 GII.4 17640 12,042,724 7163 0.06 976
A 13–39 GII.4 23606 4,301,150 12,373 0.29 121
B 14–55 GII.6 60400 3,950,778 22,326 0.57 223
B 14–56 GII.6 9814 12,493,937 7939 0.06 121.5
C 15–58 GII.4 20159 2,730,201 8766 0.32 75.5
C 15–59 GII.4 61600 3,473,043 29,427 0.85 261
D 15–65 GII.6 6268 5,406,137 2946 0.05 309.5
D 15–66* GII.6 2706 12,156,220 566 0.00 72
Viral titre is calculated as genome copies/µl. *Consensus sequence obtained from 15–65 was used as a reference for the assembly of 15–66.
conducted using a One-Step RT-PCR kit (Qiagen) according
to the manufacturer’s instructions and primers as described
previously (Mattison et al., 2010). Following electrophoresis and
in-gel visualization, the amplified products were extracted with
the Qiagen gel-purification kit and were sequenced with an
ABI3130 Genetic Analyzer to validate NoV infection and for
genotype determination.
Viral titres were determined by droplet digital PCR (Bio-Rad,
Hercules, California, USA) (Racki et al., 2014) using the probes
and primers that were described previously (Kageyama et al.,
2003). For this purpose, 20µL of each reactionmix was converted
to droplets with theQX200 droplet generator (Bio-Rad). Droplet-
partitioned samples were then be transferred to a 96-well plate,
sealed and cycled in a C1000 deep well Thermocycler (Bio-
Rad) under the following cycling protocol: 42◦C for 30min (RT)
and 95◦C for 5 min (DNA polymerase activation), followed by
45 cycles of 95◦C for 30 s (denaturation) and 50◦C for 1 min
(annealing) followed by post-cycling steps of 98◦C for 10min
(enzyme inactivation), and then an infinite 4◦C hold. The cycled
plate was transferred and read in the FAM and HEX channels
using the QX200 reader (Bio-Rad).
RNA-Seq Library Preparation
The quality and quantity of extracted RNA was examined
using Agilent RNA 6000 Pico Assay Kit and Protocol
(Agilent Technologies, Santa Clara, California, USA). Ethanol
precipitation of RNA was performed prior to proceeding to
TruSeq Stranded mRNA (Illumina, San Deigo, California, USA)
sample preparation according to the manufacturer’s instructions.
Briefly, RNA pellets from ethanol precipitates were suspended
in Elute, Prime, and Fragment Mix solution, followed by
tagmentation at 94◦C for 8min. The first strand cDNA synthesis
was conducted using SuperScript III (ThermoFisher Scientific,
Waltham, Massachusetts, USA) and random hexamer primers
at 25◦C for 10min, 50◦C for 50min, 70◦C for 15min. Second
Strand Master Mix was added into the original reaction mixture
and used to synthesize the second cDNA strand at 16◦C for
60min. The Agencourt AMPure XP—PCR Purification system
(Beckman Coulter Canada, Mississauga, Ontario, Canada)
was used to purify the complete double-stranded cDNA. Next
A-Tailing Mix was added to the purified cDNA by incubating at
37◦C for 30 min to adenylate the 3′ ends. Ligation to commercial
adapters, a thymidine overhang from the indexed paired-ends
adapters, was conducted at 30◦C for 10min by adding DNA
Ligase Mix and adapters to the sample DNA. To stop the ligation,
Stop Ligase Buffer was added into the reaction mixture. The
Agencourt AMPure XP—PCR Purification system (Beckman
Coulter Canada) was used to purify adapter-ligated-DNA
products. Library enrichment was performed by adding a PCR
MasterMix at 98◦C for 30 s and 16 cycles of 98◦C for 10 s,
60◦C for 30 s, and 72◦C for 30 s, with a final extension at 72◦C
for 5min. The enriched library was purified by the Agencourt
AMPure XP—PCR Purification system (Beckman Coulter
Canada), followed by elution with Resuspension Buffer. DNA
quantity and quality was measured using Agilent High Sensitivity
DNAAssay (Agilent Technologies) as well as the Quant-iT High-
Sensitivity dsDNA Assay (ThermoFisher Scientific). The sample
preparations were pooled at a concentration of 1 nM of DNA.
Freshly diluted NaOH (0.2N) was added to equal volumes of
the DNA libraries for denaturation, followed by further dilution
with pre-chilled HT1 buffer to obtain a final concentration of 8
pM in a total volume of 1ml. A 1% final PhiX concentration was
added to the denatured DNA for use as an internal control. The
prepared DNA library was loaded into a 150 cycle MiSeq Reagent
Kit v3 and paired-end sequenced for 76 bp in each direction. The
data demonstrated in this article are obtained from the sum of
two MiSeq runs. The yield for the first run was 4.52 Gbp (35.1 M
reads) and for the second run was 4.78 Gbp (41.3 M reads).
Sequence Assembly and Analysis
The raw sequence reads for each sample consisted primarily
of non-NoV reads; therefore, preliminary computational steps
needed to be used to ensure an adequate NoV assembly. An
in-house database was created that comprised all of the NoV
sequences available from NCBI. This database included both
complete and partial NoV genomes as well as all available
complete and partial open reading frames and coding sequence
(CDS) genes. The raw sequence reads for each sample were
aligned, using the BLASTn algorithm, to the in-house NoV
database, all reads that matched a database entry were binned
by the corresponding hit’s GenInfo Identifier (GI). Each bin
was inspected to identify which NoV database sequences were
hit, how many sequence reads were associated with a given
GI number, and which complete NoV genome entry had the
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most hits from a sample. To produce a de novo whole genome
assembly from sequence reads matching the NoV database bins
were concatenated and concatenated reads were assembled into
contigs using SPAdes (Bankevich et al., 2012).
Additionally, the previously identified closed genome with
the highest number of associated reads was then used in
a reference guided assembly using SMALT v 0.7.4 (https://
sourceforge.net/projects/smalt/). SMALT was chosen because we
have already observed that it performed well with low coverages
and when using distant references (Pightling et al., 2014). This
was performed to identify variants to the reference genome.
Variants were reported using Bcftools (Li, 2011).
The custom script and database used to perform assemblies
is available at https://sourceforge.net/projects/norobin. The
SRA accession numbers of each de novo assembly are as
follows: SRR3441741, SRR3458065, SRR3458066, SRR3458067,
SRR3458068, SRR3458069, SRR3458070, SRR3458071.
Throughout this article, we refer to the variations within
the viral quasispecies as single nucleotide variations (SNV), and
the variations between the consensus sequences obtained from
de novo assemblies as single nucleotide polymorphisms (SNP).
Phylogenetic Analysis
The NoV consensus sequences obtained from each de novo
assembly were aligned with chosen reference genomes
obtained from GenBank using MUSCLE (Edgar, 2004). The
phylogenetic trees were constructed from this alignment with
RAxML implementing a GTR Gamma nucleotide substitution
model (Stamatakis, 2014) using the sequences from ORF1
and ORF2.
Recombination Analysis
Potential recombination within the complete genome sequences
was screened using seven methods (RDP, GENECONV, MaxChi,
Bootscan, Chimera, SiScan, and 3Seq) implemented in the
Recombination Detection Program version 4.46 (RDP4) (Martin
et al., 2015). The breakpoints were also defined by RDP4.
Similarity between the recombinants and their possible major
and minor parents was estimated using BootScan, embedded in
RDP4 (Stamatakis, 2014). SimPlot (Lole et al., 1999) was used
to visualize the relationships among the recombinants and their
possible parents. The recombination event evaluated by RDP4
was considered significant if it satisfied at least 2 criteria when the
P< 0.05 and the RDP recombination consensus score (RDPRCS)
was>0.631 (Kim et al., 2016).
RESULTS
De novo Assembly of Norovirus Sequences
We obtained 8 fecal samples from 8 symptomatic NoV patients
belonging to 4 families (A–D). All samples were RT-PCR positive
for NoVGII and further analyses demonstrated that four samples
belong to GII.4 genotype (from families A and C) and four
samples belong to GII.6 genotype (from families B and D)
(Table 1).
Near-full-length genome sequences (78.9–99.9% coverage
length) were generated from all 8 samples (GenBank accession
numbers: KX158279, KX158280, KX158281, KX158282,
KX158283, KX158284, KX158285, KX158286). The total number
of sequence reads from each sample varied between 2.7 and 12.5
million (Table 1) and the proportion of reads that matched a
NoV reference sequence also varied between 0.005 and 0.85%
of the total sequence reads. This observation is consistent with
previous reports for other RNA viruses (Wong et al., 2013).
Average coverage depth across genomes was 72- to 976-fold with
an average of 270-fold (Table 1). It appears that the minimum
number of sequence reads required to obtain an accurate
full-length consensus sequence for norovirus was 2900 (Table 1).
There was not a correlation between total number of reads and
percentage of viral reads (r = −0.565). Seven out of 8 sequenced
samples produced sufficient reads to allow 90% of the reference
genome bases to be called. However, sample 15–66 yielded a
low number of reads therefore we used the 15–65 sequence as a
reference for the assembly of 15–66.
The Relation between Viral Titre and Depth
of Coverage
Whole genome sequence analyses of other RNA viruses have
demonstrated that the depth of coverage improves by increasing
viral load (Wong et al., 2013; Logan et al., 2014). To elucidate
if the correlation between NoV viral titre and the depth of
coverage was linear, we plotted the total number of viral reads
versus viral titre (genome copies/µl). As shown in Figure 1, we
observed a strong correlation (r = 0.972) between viral titer
and depth of coverage. Samples with highest viral load exhibited
higher coverage, while samples with lower titre yield low
coverage.
Distribution of Viral Reads
We examined genome-wide depth of coverage for each of the
genomes by measuring the number of reads per position. The
coverage across the length of the genome was not even. Sequence
coverage was the highest in themid ORF1 andORF2 regions, and
lower at the 5′and 3′ ends of genomes (Figure 2). This finding
is consistent with other studies reporting difficulty in recovering
readable fragments from Illumina short-read sequences at the
end of DNA molecules (Mortazavi et al., 2008; Batty et al.,
2013). The overall coverage profile was consistent between the
linked genomes (Figure 2), as well as between genomes from
the same genotype (Supplementary Figure 1). This suggests that
the depth of coverage can be affected by an intrinsic property
of the viral RNA genome. All sequenced genomes had low
coverage depth at the intersection of ORF1-ORF2 (Figure 2).
This could be explained by the presence of highly conserved
and functional structured region at the junction of ORF1-ORF2
(Simmonds et al., 2008; Alhatlani et al., 2015). There is evidence
that the 5′-end of ORF2 and the subgenomic RNA (sgRNA)
contains extensive RNA secondary structures that function as the
promoter for ORF2. Disruption of these evolutionarily conserved
RNA stem-loops severely decreases viral replication (Simmonds
et al., 2008; Alhatlani et al., 2015). Therefore, our observations
further suggest that RNA secondary structures appear to interfere
with coverage depth.
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FIGURE 1 | Correlation between the viral titre (genome copies/µl) and depth of coverage (reads mapped to norovirus genome).
Phylogenetic Analyses
Phylogenetic trees were constructed from the alignment of the
censuses sequences obtained from de novo assembly of complete
ORF1 (Figures 3A,B), and complete ORF 2 (Figures 3C,D)
with highly similar sequences from the NCBI database. To
assess the robustness of each node, a bootstrap resampling
process was performed (1000 replicates) and demonstrated
at each node. As shown, the phylogenetic relationships
between GII.4 sequences (13–38, and 13–39, as well as 15–
58, and 15–59, from families A and C respectively) and their
closest relatives remain similar for both ORF1 and ORF2
(Figures 3A,C). Sequences obtained from 13–38, and 13–
39 cluster with GII.4-Hu-CUHK3630-2012-HongKong-CHN
(Accession No: KC175323), GII.4-Hu-Sydney2012-Fukuyama-
JP-2 (Accession No: KJ196280), and GII.4-Hu-NG1242-2011-JP
(Accession No: AB972502). Sequences obtained from 15–58 ad
15–59 show homology to GII.4-Hu-Iwate5-2012-JP (Accession
No: AB972473) at both ORFs. However, the phylogenetic
relationships between GII.6 sequences (14–55, 14–56 from family
B and 15–65, 15–66 from family D) and their closest relatives
differ slightly between ORF1 and ORF2 (Figures 3B,D). It
appears that there is more distance between 15–65 and 15–66
sequences and their reference (GII.6-Hu-NHBGR59, Accession
No: KU870455) at ORF1 compared to ORF2, as there are 231
SNPs between these genomes and their reference at ORF1,
while only 61 SNPs were detected at ORF2 (Figures 3A,B).
Sequences obtained from 14–55 and 14–56 showed homology to
GII.6/2014/Groningen (Accession No: LN854568).
Investigation of SNVs Across the NoV
Genome
Multiple lines of evidence suggest that the diversity of the
NoV quasispecies in infected individuals with a normal immune
system is quite low (Bull et al., 2012; Karst and Baric, 2015).
We observed a high similarity between the consensus sequences
obtained from linked patients. However, there were several SNPs
between the linked genomes that are listed in Table 2. While
the consensus sequences obtained from family C (15–58/15–59)
showed 100% similarity, the consensus sequences gained from
family A (13–38/13–39), family B (14–55/14–56), and family D
(15–65/15–66) demonstrated 2, 1, and 4 SNPs across genome,
respectively (Table 2).
High coverage depth facilitates identifying a variety of unique
intra-host variants at different frequencies. The variability of
nucleotides observed at each position of the sequenced NoV
genomes (with coverage depth of 10-fold or higher) was assessed
by analysis of sequence variations at each genome position, and
demonstrated in dot plots for each family (Figure 4). Since the
anticipated sequence error rate for Illumina is approximately
2% (Erik Garrison, 2012; Hasing et al., 2016), genetic variations
that occur at frequencies higher than 2% can potentially be
natural SNVs. As demonstrated in Figure 4, the areas with
higher variability are observed at the RdRP, VP1, and the
VP2 (ORF3) regions with variant frequency of 5% or higher
(Figure 4).
When mutations occur in the VP1 (ORF 2) protein, it
leads to antigenic variation and subsequent immune evasion
(White, 2014). The VP1 protein has three main domains: an
N-terminal domain (N), a highly conserved shell domain (S),
and a protruding domain (P) which forms surface-exposed
spikes on the virus surface. The P domain is further divided
into hypervariable domain (P2) and a more conserved P1
domain (P1) (Shanker et al., 2011; Debbink et al., 2012). Within
the P2 subdomain 5 highly variable blockade epitopes have
been defined (A–E). These epitopes surround the histoblood
group antigen (HBGA) binding pocket, Epitope A is considered
to be the most important determinant of antigenic variation
(Lindesmith et al., 2013). However, other residues adjacent to
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FIGURE 2 | Distribution of NoV reads across the sequenced genomes. Coverage was calculated as the total number of reads covering a given nucleotide and
was normalized by the sum of total coverage across the genome. i.e., at each residue, the coverage was divided by the total coverage and the sum of normalized
coverage equals one. (A–D) read coverage for the linked patients from families (A–D) (Table 1). Schematic representation of the NoV encoded proteins is shown
below the graphs
these epitopes might also impact NoV affinity to HBGAs and
binding to neutralizing antibodies (Giammanco et al., 2014;
White, 2014).
To study the variation within the VP1 protein between
the patients infected with the same genotype, we performed
amino acid sequence alignment of VP1 protein (Figures 5A,B).
Amino acid sequence alignment of GII.4 Sydney-2012 samples
demonstrated no coding change in the conserved N and S
domains, 4 in the P1 domain, and 3 in the P2 domain with
D376E falling in the C epitope and D391N in the D epitope.
Also one non-synonymous change was detected in the C domain
(Figure 5A).
Unlike the GII.4 Sydney-2012 isolates, the GII.6 isolates do
not belong to the same strain (Figure 3). Therefore, higher amino
acid sequence variability is expected in the complete VP1 protein
of GII.6 isolates (Figure 5B). The number of non-synonymous
differences between samples 14–55, 14–56, and 15–65, 15–66
was 1, 2, 10, 34, and 3 for N, S, P1, P2, and C domains,
respectively. Each blockade epitope had non-synonymous SNPs,
with 5 differences in epitope A (T294N, S295A, S297A, V368A,
N374D). These differences may have a marked effect on the
antigenicity, since it has been previously shown that residues 294
and 368 play key roles in the blockade responses (Vongpunsawad
et al., 2013). Two stretches of coding differences that are not
within the putative epitopes: one A304P, P305Q, V307A and a
relatively longer stretch N351D, T352V, T353S, S355T, S356Q,
I357E, G358Q (Figure 5B) were observed. While most of these
coding differences exist in the reference genomes, there are
several unique coding changes that are only present in the
genomes sequenced in this study such as D395I (15–65 and 15–
66) and S521P (14–55 and 14–56). Collectively, these data suggest
that strains belonging to the same genotype can be antigenetically
different, and this supports the hypothesis that the emergence
of new strains within a certain genotype is the result of escape
from herd immunity as they undergo evolution in antigenic and
surface-exposing residues.
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FIGURE 3 | Phylogenetic analysis of the NoV genomes identified in this study. The consensus sequences of the ORF1 for GII.4 (A) and GII.6 (B) sequences
respectively, and ORF2 for GII.4 (C) and GII.6 (D) from each assembly were then aligned with highly similar sequences from GenBank database. The robustness of the
phylogeny was assessed through bootstrap analysis of 1000 pseudo-replicates. The accession numbers for the reference genomes are provided in parentheses. The
scale bars represent the number of substitutions per site.
TABLE 2 | Single nucleotide polymorphisms between the linked genomes.
Family Linked genomes Position* Region Variation
A 13–38/13–39 829 ORF1 G/A
7447 ORF3 C/T
B 14–55/14–56 3133 ORF1 G/A
C 15–58/15–59 – – None
D 15–65/15–66 346 ORF1 G/A
1102 ORF1 C/T
1114 ORF1 A/G
3484 ORF1 C/T
*Nucleotides are numbered according to the NoV GII4/2012/Sydney (Accession No:
KM258128).
Recombination Analyses
Recombination is a significant source of genetic diversity in
NoVs. This phenomenon, which occurs during co-infection
with different strains, is usually observed at the ORF1-
ORF2 and ORF2-ORF3 junctions (White, 2014). There is
growing evidence that the recombination rate is increasing
among noroviruses (Bull et al., 2012; Wong et al., 2013;
Lim et al., 2016); however, the lack of sufficient full-
length NoV sequence data has hindered the search for
inter- and intra-genotype recombination, and has limited the
understanding of how recombination affects NoV evolution
(Eden et al., 2013). Therefore, in this study we investigated
the incidence of recombination throughout the NoV genomes.
Through phylogenetic analysis and separate genotyping of
ORF1, and ORF2 regions using Noronet genotyping tool
(Kroneman et al., 2011), it was found that all GII.4 Sydney
2012 genomes possessed the original GII.Pe ORF1 (Martella
et al., 2013, Table 3) and all GII.6 genomes were associated
with GII.P7 ORF1, which is a predominant recombination
variant of GII.6 strains (Fumian et al., 2016; Lim et al.,
2016).
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FIGURE 4 | Distribution of single nucleotide variants (SNVs) across the sequenced NoV genomes. Schematic representation of the NoV encoded proteins is
shown above the graphs. (A–D), graphs represent SNV frequency at each position for families (A–D).
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FIGURE 5 | Non-synonymous differences within the structural domains of the capsid protein (VP1, ORF2), which are the N-terminal (N), shell (S), P1,
and P2 domains. (A) Non-synonymous differences between the sequenced GII.4 Sydney genomes (families A and C) and their references (B) amino acid differences
between the sequenced GII.6 genomes (families B and D) and their references. Individual epitope sites are highlighted in different colors: Yellow, epitope site A; blue,
epitope site B; gray, epitope site C; orange, epitope site D; pink, epitope site E. Stretches of amino acid differences are shown in red. Residues are numbered
according to the NoV GII4/2012/Sydney (Accession No: KM258128).
To perform an in depth analyses of recombination, a
genome-wide examination of sequences from the same genotype
using RDP4 was preformed (Figure 6). This program analyses
sequences for the presence of recombination using seven
different recombination detection methods (RDP, GeneConv,
Bootscan, MaxChi, Chimaera, SiScan, and 3Seq), and provides
the statistical probability of each recombination event (Martin
et al., 2015). As shown in Figure 6, there is evidence of a
major recombination event between the 15–65, 15–66, and
GII.4 Sydney (Accession No: KM258128) genomes at nucleotide
positions 3527–5163, which encompasses the 3′ end of the ORF1.
This recombination event was unique to 15–65, 15–66 genomes
and was not detected in 14–55 and 14–56 genomes. Moreover,
further recombination analysis by RDP4 demonstrated that all
the GII.4 Sydney genomes (13–38, 13–39, 15–58, and 15–59)
contained the same polymerase (GII.Pe), which is considered a
signature of the pandemic Sydney 2012 strains (Martella et al.,
2013) (data not shown).
DISCUSSION
Noroviruses are genetically diverse and this heterogeneity
increases the adaptability and fitness of certain variants. Novel
antigenic variants can emerge and escape herd immunity
or strains with increased replication rate or environmental
persistence can appear that spread more rapidly and efficiently
than others. NoVs genetic diversity is influenced by viral factors
such as polymerase errors, genetic recombination, and host
factors, such as the immune response. It has been hypothesized
that inter- and intra-host genetic heterogeneity can act as a
reservoir for new variants. Since NoV, like many other RNA
viruses, exists as a swarm of quasispecies, it is not clear
how much genetic variation can be expected during direct
transmission of an acute infection. Therefore, the virus that is
isolated from the source of transmission might not necessarily
be genetically identical to the virus isolated from the immediate
patient. Knowing the range of variation possible between each
transmission event is valuable, and our study examined the
genetic diversity between a primary and a secondary infection
during a single person-to-person transmission events. This is the
first step toward facilitating more accurate source attribution as
well as establishing a method for determining the directionally of
transmission during outbreaks.
Noroviruses generally cause acute and self-limiting infections,
therefore we aimed to examine the intra- and inter-patient
genetic variations throughout the entire NoV genome isolated
from symptomatic, acutely infected, linked patients. For that
purpose, next-generation sequencing was used to analyze whole
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TABLE 3 | Recombination analysis using Noronet genotyping tool.
Sample ID Length ORF1 genotype ORF2 genotype ORF1 genotype support ORF2 genotype support
13–38 7542 GII.Pe GII.4 Sydney_2012 100 100
13–39 7512 GII.Pe GII.4 Sydney_2012 100 100
15–58 5963 GII.Pe GII.4 Sydney_2012 100 100
15–59 7356 GII.Pe GII.4 Sydney_2012 100 100
15–55 7539 GII.P7 GII.6 100 100
14–56 7491 GII.P7 GII.6 100 100
15–65 7586 GII.P7 GII.6 100 100
15–66 7330 GII.P7 GII.6 100 100
FIGURE 6 | Recombination analyses of the full genomes of norovirus. A sliding window of 200 nt was utilized to make the SimPlot. SimPlot was generated for
the linked recombinant genomes 15–65 and 15–66. Two breakpoints were identified, which leads to production of a mosaic genome that has a GII.6 backbone with
an insertion from a GII.4 Sydney. Schematic representation of the NoV genome is shown above the graph.
NoV genomes obtained from clinical samples of 8 linked patients
(4 GII.4 and 4 GII.6) belonging to 4 families. We selected NoV
GII.4 for examination in this investigation because it is the
predominant genotype in the North America (de Graaf et al.,
2015, 2016), and GII.6 since it is the second most prevalent
genotype (Chan-It et al., 2012; Vega et al., 2014; Luo et al., 2015;
Xue et al., 2015).
To design a WGS strategy that was unbiased by sequence-
specific primers, we employed a metagenomic approach for
RNA-Seq on IlluminaMiSeq platform to sequence NoV genomes
directly from clinical samples. By selecting only sequence-reads
that aligned to known NoV sequences, de novo assembly of the
entire NoV genome was possible (Table 1). High coverage-depth
made it possible to identify minor variants at each nucleotide
position. We have shown that clinical samples contain sufficient
viral RNA to perform successful virus WGS, despite the presence
of sequence reads from other sources such as the host, dietary
materials, and microbial RNA. Only one sample (15–66), which
also had the lowest viral load, did not yield sufficient reads for
de novo assembly and therefore we performed reference-guided
assembly using its linked genome, 15–65, as the reference. Overall
the bases which could not be sequenced were clustered at the ends
of the genome, which consistently yields low coverage (Figure 2).
Low coverage at the ends of the genome is consistent with other
reports that the 5′ and 3′ terminals of viral RNA genomes are
difficult to sequence (Batty et al., 2013). This is particularly
evident in samples with low viral titre, suggesting that increasing
the input RNA of such samples could improve coverage. We
confirmed the correlation between depth of coverage and viral
load by plotting coverage against the viral titre and calculating the
Pearson correlation coefficient (Figure 1). However, in a study
conducted on Measles virus, no correlation was found between
the viral titre in samples and the fraction of the genome covered
(Penedos et al., 2015).
Variability in coverage and sequencing depth across the
genome was observed with all samples; however, overall coverage
profile in the linked genomes, as well as genomes that belong
to the same genotype, is strikingly similar (Figure 2 and
Supplementary Figure 1). While the reason for this observation
is not clear, we hypothesized that the presence of RNA secondary
structures in the viral genome influences the coverage depth
and since the linked genomes have very similar sequences
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(Table 2), it is assumed that their secondary and tertiary RNA
structures are also similar, which yield similar coverage profile.
This assumption was further supported by the observation that
in all the sequenced genomes, the coverage decreases at the
junction of ORF1 and ORF2, where a highly structured promoter
for ORF2 exists (Figure 2, Simmonds et al., 2008; Alhatlani
et al., 2015; Yunus et al., 2015). The negative effect of RNA
secondary structure on depth of coverage produced by RNA-Seq
has been recently reported by other researchers as well (Biswas
and Gao, 2016). RNA structure can affect target accessibility and
limit the efficiency of RNA tagmentation and cDNA synthesis.
Therefore, a heat-denaturation step prior to RNA tagmentation
and cDNA synthesis may improve coverage for WGS of RNA
viruses. Moreover, the overall coverage profile obtained from our
sample is consistent with what Batty and colleagues have formerly
reported (Batty et al., 2013).
For the phylogenetic analysis, a comparison was made in the
genetic distance between the genomes sequences assembled in
this study and their highly similar relatives for both ORF1 and
ORF2 (Figure 3). While the genetic distance for the GII.4 Sydney
genomes (13–38, 13–39, 15–58, and 15–59) remained consistent
for both ORF1 and ORF2, 15–65 and 15–66 sequences that
belong to GII.6 appeared to be closer to their reference GII.6-Hu-
NHBGR59 in ORF2 when compared to ORF1. This phenomenon
can be explained by the presence of a recombination event at the
end of ORF1 for these genomes (Figure 6).
As expected, there are limited numbers of nucleotide
differences between the consensus sequences obtained from
linked genomes (Table 2). Nevertheless, it is notable that the
SNPs that are observed between the linked genomes are missing
in the reference genomes (data not shown), this might indicate
that these SNPs uniquely occurred during the single transmission
events.
Due to high coverage-depth, a variety of unique intra-host
SNVs throughout the sequenced genomes was identified. The
anticipated sequencing error rate by Illumina technology is
approximately 2% (Bravo and Irizarry, 2010; Beerenwinkel et al.,
2012) therefore it is generally accepted that genetic variations
with frequencies ≥ 2 % and ≥ 5X coverage can be considered
as potential SNVs (Erik Garrison, 2012). Other groups have
also employed similar approach to identify SNVs within viral
quasispecies (Faison et al., 2014; Penedos et al., 2015; Hasing
et al., 2016; King et al., 2016). In this study the SNV frequency
has been only demonstrated for the positions with 10-fold or
higher coverage. While there are low frequency variants that can
be considered as sequencing or amplification errors, many of
high frequency variants, for example those that clustered within
ORF2, the 3′ end of ORF1 and ORF3 (Figure 4) can potentially
be natural occurring intra-patient SNVs.
The distribution of SNVs indicates that intra-host viral
populations were more homogenous for patients in families A
and B, with only a few SNVs above 5%. In contrast, patients
within families C and D presented a more heterogeneous intra-
host population, as multiple SNVs with a frequency of 5%
or higher in the viral population were distributed across the
entire length of the genome. Overall, we observed that some
regions of the NoV genomes are particularly prone to mutation
(variant frequency > 5%). It has also been demonstrated that
during direct viral transmissionsminor variants within the donor
viral quasispecies can present as major variants or consensus
sequences in the recipient viral population (Kundu et al., 2013;
Holzknecht et al., 2015). Therefore, epidemiological data together
with deepWGS data obtained from linked cases and transmission
chains can provide efficient means for source attribution and
may help to identify signatures and patterns in the mutations
throughout the viral genomes. In the future this may enable
us to predict strain emergence, viral evolution, and allow us to
intervene sooner in an outbreak setting.
Amino acid variations in the complete VP1 protein, including
the P2 domain were analyzed. Interestingly there are several non-
synonymous differences between the closely related GII.4 Sydney
genomes (Figure 5A), with two amino acid changes falling within
the antigenic epitope C and D. These changes can potentially
alter the antigenic profile of these viruses and lead to escape
from herd immunity. However, in-depth analyses are required
to confirm this hypothesis. Amino acid variations were more
common between the sequenced GII.6 genomes; specifically
the P2 domain contained the most variability with 34 amino
acid substitutions (Figure 5B). However, the N domain and S
domain of the capsid protein were highly conserved. We also
screened the antigenic epitope sites for the presence of non-
synonymous changes and identified variations in all 5 blockade
epitopes, including 5 differences in epitope A, 4 in epitope B, 2 in
epitopes C, D, and E. These findings are particularly interesting
as these epitopes have been shown to modulate HBGA binding
and neutralization responses (Giammanco et al., 2014; White,
2014). Therefore, our data supports the hypothesis that immune
evasion by antigenic variation at neutralizing epitopes is a driving
mechanism behind new NoV strain emergence.
Most of the recombination events for noroviruses have been
observed at the ORF1/2 overlap, which allow the exchange of
nonstructural and structural genes, and therefore contribute
to the emergence of new epidemic strains (Eden et al., 2013;
de Graaf et al., 2016). Herein we also identified GII.P7/GII.6
recombinant viruses that are frequently reported and, unlike
the other detected recombinant strains, have long period of
circulation (since 2004) (Fumian et al., 2016; Lim et al., 2016).
Moreover, we identified a novel inter-genotypic recombination
event at the 3′ end of ORF 1 for 15–65 and 15–66 genomes
(Figure 6), which led to the production of a mosaic genome with
GII.6 backbone and GII.4 Sydney insertion. This observation
is further validated by the phylogenies of the ORF 1 region
presented in this study (Figures 3A,B). The acquisition of novel
ORF1 regions has also been suggested to increase viral fitness
that contribute to strain emergence, for example, by altering the
replication rate or polymerase fidelity (Eden et al., 2013).
In conclusion, a metagenomic NGS approach can be
employed to successfully sequence the whole genome of NoVs
directly from clinical samples, without the need for sequence-
specific enrichment. In this study, as proof-of-principle, we
sequenced each sample to a very high-coverage then recovered
and analyzed near-complete genome sequences from 8 linked
patients. Processing higher number of samples per MiSeq run,
and thus lowering the sequence coverage, would decrease the
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sequencing cost. We demonstrated that while de novo assembly
may not be possible at lower level of coverage, reference guided
assembly can be an effective alternative if a close reference exists.
Sequence data obtained from this approach can be used to
comprehensively analyze intra- and inter- host genetic variation
and identify recombination events throughout the NoV genome.
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